<DOC>
	<DOCNO>NCT00362778</DOCNO>
	<brief_summary>Hyperglycemia admission associate bad prognosis patient acute myocardial infarction ( AMI ) . The clinical benefit intensive treatment insulin evaluate diabetic patient admit intensive care unit . The aim study ass short-term effect safety strict glycemic control subject AMI hyperglycemia without previous history diabetes .</brief_summary>
	<brief_title>Intensive Insulin Therapy Non-diabetic Patients With Acute Myocardial Infarction Hyperglycaemia</brief_title>
	<detailed_description>Twenty-eight non-previously diabetic patient admit AMI hyperglycemia randomize two treatment arm , administer first 48 hour : intensive group ( n=13 ) receive intravenous insulin target glycemia level 80-110mg/dL , conventional group ( n=15 ) receive subcutaneous insulin glycemia Â³ 160mg/dL . High-sensitivity C-reactive protein ( HS-CRP ) determine 48 hour discharge oral glucose tolerance test ( OGTT ) perform 1 month .</detailed_description>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Hyperglycemia</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>1 . Confirmed diagnosis AMI , either without ST segment elevation 2 . Presence high blood glucose admission previously know diabetes mellitus ( DM ) 1 . Age 18 year old 2 . History DM 3 . Presence cardiopathy ( dilate cardiomyopathy , valvular hypertrophic heart disease ) 4 . Unstable AMI patient ( haemodynamic instability arrhythmic disorder ) 5 . Platelet aggregation coagulation disorder 6 . Severe condition estimate short ( 1 year ) life expectancy 7 . Participation trial 8 . Patient refusal participate study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2012</verification_date>
</DOC>